Overexpression of Adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety

Copyright: © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, p...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in psychiatry Vol. 5; p. 67
Main Authors Coelho, Joana, Nascimento Alves, Pedro, Canas, Paula M., Valadas, Jorge S., Shmidt, Tatiana, Batalha, Vânia, Ferreira, Diana G., Ribeiro, Joaquim, Bader, Michael, Cunha, Rodrigo A., Simões do Couto, Frederico, Lopes, Luisa
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers 2014
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Copyright: © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D2 receptors. Although this reciprocal antagonistic interaction is well-established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A2AR associated to aging and chronic stress. Furthermore, Alzheimer's disease patients present A2AR accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A2AR in forebrain neurons on dopamine-related behavior, namely depression. Adult male rats overexpressing human A2AR under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT), and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion, and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48 h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion, and altered exploratory behavior. This A2AR overexpression may explain the depressive signs found in aging, chronic stress, and Alzheimer's disease. Joana E. Coelho, Vânia L. Batalha and Diana G. Ferreira were supported by a grant from Fundação para a Ciência e Tecnologia (FCT); Paula M. Canas and Rodrigo A. Cunha were supported by FCT (PTDC/SAU-NSC/122254/2010) and Defense Advanced Research Projects Agency (DARPA, grant 09-68-ESR- FP-010). Luísa V. Lopes is an Investigator FCT, funded by Fundação para a Ciência e Tecnologia (PTDC-099853/2009) and Bial.
AbstractList Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D2 receptors. Although this reciprocal antagonistic interaction is well established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A2AR associated to aging and chronic stress. Furthermore, Alzheimer’s disease patients present A2AR accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A2AR in forebrain neurons on dopamine related behavior, namely depression. Adult male rats overexpressing human A2AR under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT) and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion and altered exploratory behavior. This A2AR overexpression may explain the depressive signs found in aging, chronic stress and Alzheimer’s disease.
Adenosine A 2A receptors (A 2A R) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D 2 receptors. Although this reciprocal antagonistic interaction is well-established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A 2A R associated to aging and chronic stress. Furthermore, Alzheimer’s disease patients present A 2A R accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A 2A R in forebrain neurons on dopamine-related behavior, namely depression. Adult male rats overexpressing human A 2A R under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT), and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion, and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48 h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion, and altered exploratory behavior. This A 2A R overexpression may explain the depressive signs found in aging, chronic stress, and Alzheimer’s disease.
Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D2 receptors. Although this reciprocal antagonistic interaction is well-established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A2AR associated to aging and chronic stress. Furthermore, Alzheimer's disease patients present A2AR accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A2AR in forebrain neurons on dopamine-related behavior, namely depression. Adult male rats overexpressing human A2AR under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT), and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion, and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48 h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion, and altered exploratory behavior. This A2AR overexpression may explain the depressive signs found in aging, chronic stress, and Alzheimer's disease.
Copyright: © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine D2 receptors. Although this reciprocal antagonistic interaction is well-established in motor function, the outcome in dopamine-related behaviors remains uncertain, in particular in depression and anxiety. We have demonstrated an upsurge of A2AR associated to aging and chronic stress. Furthermore, Alzheimer's disease patients present A2AR accumulation in cortical areas together with depressive signs. We now tested the impact of overexpressing A2AR in forebrain neurons on dopamine-related behavior, namely depression. Adult male rats overexpressing human A2AR under the control of CaMKII promoter [Tg(CaMKII-hA2AR)] and aged-matched wild-types (WT) of the same strain (Sprague-Dawley) were studied. The forced swimming test (FST), sucrose preference test (SPT), and the open-field test (OFT) were performed to evaluate behavioral despair, anhedonia, locomotion, and anxiety. Tg(CaMKII-hA2AR) animals spent more time floating and less time swimming in the FST and presented a decreased sucrose preference at 48 h in the SPT. They also covered higher distances in the OFT and spent more time in the central zone than the WT. The results indicate that Tg(CaMKII-hA2AR) rats exhibit depressive-like behavior, hyperlocomotion, and altered exploratory behavior. This A2AR overexpression may explain the depressive signs found in aging, chronic stress, and Alzheimer's disease. Joana E. Coelho, Vânia L. Batalha and Diana G. Ferreira were supported by a grant from Fundação para a Ciência e Tecnologia (FCT); Paula M. Canas and Rodrigo A. Cunha were supported by FCT (PTDC/SAU-NSC/122254/2010) and Defense Advanced Research Projects Agency (DARPA, grant 09-68-ESR- FP-010). Luísa V. Lopes is an Investigator FCT, funded by Fundação para a Ciência e Tecnologia (PTDC-099853/2009) and Bial.
Author Bader, Michael
Canas, Paula M.
Shmidt, Tatiana
Simões do Couto, Frederico
Coelho, Joana
Batalha, Vânia
Nascimento Alves, Pedro
Ribeiro, Joaquim
Lopes, Luisa
Valadas, Jorge S.
Ferreira, Diana G.
Cunha, Rodrigo A.
AuthorAffiliation 5 Max-Delbrück-Center for Molecular Medicine (MDC) , Berlin , Germany
4 Faculty of Medicine, University of Coimbra , Coimbra , Portugal
1 Faculty of Medicine of Lisbon, Instituto de Medicina Molecular, University of Lisbon , Lisbon , Portugal
2 Faculty of Medicine of Lisbon, Institute of Pharmacology and Neurosciences, University of Lisbon , Lisbon , Portugal
3 CNC-Center for Neurosciences and Cell Biology, University of Coimbra , Coimbra , Portugal
AuthorAffiliation_xml – name: 2 Faculty of Medicine of Lisbon, Institute of Pharmacology and Neurosciences, University of Lisbon , Lisbon , Portugal
– name: 3 CNC-Center for Neurosciences and Cell Biology, University of Coimbra , Coimbra , Portugal
– name: 4 Faculty of Medicine, University of Coimbra , Coimbra , Portugal
– name: 1 Faculty of Medicine of Lisbon, Instituto de Medicina Molecular, University of Lisbon , Lisbon , Portugal
– name: 5 Max-Delbrück-Center for Molecular Medicine (MDC) , Berlin , Germany
Author_xml – scopusid: 7101840699
  sequence: 1
  givenname: Joana
  orcidid: 0000-0002-3964-6197
  surname: Coelho
  fullname: Coelho, Joana
– sequence: 2
  givenname: Pedro
  orcidid: 0000-0001-5740-5904
  surname: Nascimento Alves
  fullname: Nascimento Alves, Pedro
– sequence: 3
  fullname: Canas, Paula M.
– sequence: 4
  givenname: Jorge S.
  orcidid: 0000-0002-2126-9485
  surname: Valadas
  fullname: Valadas, Jorge S.
– sequence: 5
  fullname: Shmidt, Tatiana
– sequence: 6
  givenname: Vânia
  orcidid: 0000-0001-6657-1111
  surname: Batalha
  fullname: Batalha, Vânia
– sequence: 7
  fullname: Ferreira, Diana G.
– scopusid: 35498669400
  sequence: 8
  givenname: Joaquim
  orcidid: 0000-0002-9330-3507
  surname: Ribeiro
  fullname: Ribeiro, Joaquim
– sequence: 9
  fullname: Bader, Michael
– sequence: 10
  fullname: Cunha, Rodrigo A.
– scopusid: 14621494400
  sequence: 11
  givenname: Frederico
  orcidid: 0000-0002-3916-2598
  surname: Simões do Couto
  fullname: Simões do Couto, Frederico
– scopusid: 7102509159
  sequence: 12
  givenname: Luisa
  orcidid: 0000-0001-8367-3005
  surname: Lopes
  fullname: Lopes, Luisa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24982640$$D View this record in MEDLINE/PubMed
BookMark eNpVkc1PGzEQxS1EBZRy76na3npoUn_H7qFShGiLhMSlPVte75gabeyt7UTkv8dJAMHB8sjzmzdPfu_RcUwREPpI8Jwxpb_5qWzrnGLC5xhjuThCZ0RKPsOS4-NX9Sm6KOW-IZhpzaQ4QaeUa0Vb6wzZ2w1keJgylBJS7JLvlgPEVEKEbkmXXQYHU025dCF22dbyvQPvwdXSNXyA58mv3ZhcWqW6r20c2nkIULcf0DtvxwIXT_c5-vvz6s_l79nN7a_ry-XNzHGpFzOlBFjwmEDfzHnSy8FTpjj3WghPRM8UIdp7S3qiLKZUMc6V1JYS2Ust2Tm6PugOyd6bKYeVzVuTbDD7h5TvjM01uBGMdIIo6mnPNOXCUesXUhKmscK8x4NoWj8OWtO6X8HgINZsxzeibzsx_DN3aWM4FkLJnZkvTwI5_V9DqWYVioNxtBHSuhgiOKVackUbig-oy6mUDP5lDcFmF7TZB212QZt90G3k02t7LwPPsTbg8wHIztrJZNiEUm1bi7kgRpD2Z-wRa82w8A
CitedBy_id crossref_primary_10_1007_s11302_018_9609_4
crossref_primary_10_1016_j_celrep_2021_109574
crossref_primary_10_1016_j_neuropharm_2022_108977
crossref_primary_10_1038_mp_2017_188
crossref_primary_10_29254_2077_4214_2022_4_167_76_83
crossref_primary_10_2217_epi_2023_0351
crossref_primary_10_1038_nn_4648
crossref_primary_10_1038_s41380_018_0110_9
crossref_primary_10_1016_j_brainresbull_2019_06_016
crossref_primary_10_3389_fnmol_2018_00475
crossref_primary_10_1038_s41392_021_00553_z
crossref_primary_10_1089_caff_2019_0022
crossref_primary_10_1038_mp_2016_173
crossref_primary_10_2174_1573406416666191227120425
crossref_primary_10_1007_s12640_022_00550_2
crossref_primary_10_1016_j_pbb_2015_05_005
crossref_primary_10_1111_jnc_14841
crossref_primary_10_1080_14728222_2020_1758667
crossref_primary_10_3390_biology12040559
crossref_primary_10_1080_07388551_2023_2231139
crossref_primary_10_3390_brainsci10030160
crossref_primary_10_1007_s12035_015_9660_x
crossref_primary_10_1111_jnc_14816
crossref_primary_10_3389_fncel_2019_00589
crossref_primary_10_1007_s12035_015_9270_7
crossref_primary_10_3390_ph15111323
crossref_primary_10_4236_abb_2023_1412037
crossref_primary_10_3389_fncel_2015_00521
crossref_primary_10_3389_fpsyt_2019_00363
crossref_primary_10_1007_s11302_016_9551_2
crossref_primary_10_1016_j_neuropharm_2019_05_003
crossref_primary_10_1016_j_phrs_2019_104338
crossref_primary_10_1016_j_ynstr_2023_100543
crossref_primary_10_1016_j_physbeh_2016_11_030
crossref_primary_10_1038_s41398_020_01183_9
crossref_primary_10_1038_s41598_022_26808_5
crossref_primary_10_3390_brainsci7030030
crossref_primary_10_1177_02698811211058975
crossref_primary_10_1016_j_ejphar_2021_174364
crossref_primary_10_1111_bph_16216
crossref_primary_10_1155_2015_575063
crossref_primary_10_1089_caff_2020_0009
crossref_primary_10_1007_s11302_020_09694_2
crossref_primary_10_1007_s12035_022_03001_3
crossref_primary_10_1016_j_neuropharm_2022_109371
crossref_primary_10_1016_j_phrs_2020_105363
crossref_primary_10_1007_s12035_023_03441_5
crossref_primary_10_1016_j_jneumeth_2022_109707
crossref_primary_10_1016_j_pharmthera_2021_107821
crossref_primary_10_1016_j_pnpbp_2019_109776
crossref_primary_10_2174_1381612825666190716113444
crossref_primary_10_1139_cjpp_2022_0098
crossref_primary_10_1111_jnc_13109
crossref_primary_10_3390_ijms23031219
crossref_primary_10_2174_1389201022666211012102501
crossref_primary_10_1016_j_bbi_2019_05_025
crossref_primary_10_1038_s41392_024_01738_y
crossref_primary_10_3389_fncel_2021_639322
crossref_primary_10_3390_cells9071739
crossref_primary_10_1080_00207454_2020_1754213
crossref_primary_10_1016_j_pbb_2023_173573
crossref_primary_10_3389_fnins_2021_702581
crossref_primary_10_1007_s12640_018_9959_2
crossref_primary_10_1111_jnc_13421
crossref_primary_10_1007_s11064_021_03263_8
Cites_doi 10.1176/appi.ajp.163.9.1594
10.1038/npp.2008.72
10.1007/s00702-010-0454-z
10.1111/bph.12234
10.1038/nrn2652
10.1523/JNEUROSCI.1538-06.2006
10.1016/j.bbr.2011.06.021
10.1023/A:1014912128311
10.1016/j.biopsych.2005.05.019
10.1016/j.biopsych.2013.05.003
10.1016/j.bbr.2005.01.005
10.1046/j.1471-4159.2001.00389.x
10.1038/41771
10.1016/j.bbr.2009.05.036
10.1016/j.prostaglandins.2008.10.001
10.1007/BF01277656
10.1111/j.1471-4159.2004.02887.x
10.1016/S0165-6147(02)02017-5
10.1111/j.1476-5381.1995.tb16421.x
10.1016/j.ejphar.2005.07.025
10.1038/mp.2012.8
10.1093/schbul/sbp006
10.1038/sj.npp.1300959
10.1016/j.tins.2007.03.006
10.1111/j.1528-1167.2010.02700.x
10.1038/sj.npp.1300876
10.1016/S0149-7634(01)00011-2
10.1016/S0149-7634(05)80192-7
10.1016/j.nlm.2006.05.004
10.1016/S0166-2236(97)01096-5
10.1038/sj.npp.1300532
10.1038/sj.npp.1300167
10.1016/S0014-2999(03)01272-X
10.1016/j.neulet.2004.12.012
10.1016/j.ejphar.2009.06.018
10.1038/sj.npp.1300852
10.2174/1874082001004020093
10.1016/j.pnpbp.2008.01.012
10.1111/j.1750-3639.2007.00112.x
10.1016/S0304-3940(00)01371-9
10.1007/BF02244188
10.1016/j.ejphar.2012.08.020
10.1176/appi.ajp.2008.08081201
10.1212/01.WNL.0000095220.87550.F6
10.1016/j.tips.2008.07.005
10.1016/j.npep.2009.12.002
10.1016/j.neuroscience.2005.01.054
10.1523/JNEUROSCI.4215-09.2009
10.1016/S0092-8674(02)00763-8
10.1124/jpet.103.062463
10.1111/j.1471-4159.2009.05876.x
10.1001/archneur.61.5.641
10.1523/JNEUROSCI.5066-06.2007
10.1111/j.1460-9568.2011.07719.x
10.1016/j.neubiorev.2005.04.016
10.1038/266730a0
10.1007/s00213-005-0284-0
10.1016/S0306-4522(02)00080-5
10.1523/JNEUROSCI.3574-05.2006
10.1038/sj.npp.1300232
10.1124/jpet.107.123844
10.1002/glia.22290
10.1016/j.physbeh.2007.05.034
10.1016/j.bbr.2005.03.009
10.1016/j.neubiorev.2005.03.008
10.1016/S0301-0082(02)00155-7
10.1016/j.neuroimage.2009.01.058
10.1007/s00213-009-1608-2
10.1016/j.bbr.2010.03.003
10.1101/SQB.1996.061.01.024
10.1016/j.ejphar.2007.01.063
10.1007/BF02245592
10.1016/0014-2999(94)90033-7
10.1016/j.neulet.2003.10.040
10.1016/j.pneurobio.2007.05.001
10.1073/pnas.97.4.1856
10.1016/0091-3057(93)90525-X
10.1016/j.neuropharm.2006.05.005
10.1007/s12264-010-0323-7
10.1038/mp.2008.119
10.1007/s002130050037
10.1124/jpet.106.103143
ContentType Journal Article
Copyright Copyright © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. 2014
Copyright_xml – notice: Copyright © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. 2014
DBID RCLKO
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fpsyt.2014.00067
DatabaseName RCAAP open access repository
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList

PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DissertationSchool Repositório da Universidade de Lisboa
EISSN 1664-0640
EndPage 67
ExternalDocumentID oai_doaj_org_article_6c5182f2b39245c2af7661390804b0d5
10_3389_fpsyt_2014_00067
24982640
10451_51216
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
ABIVO
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
IAO
IEA
IHR
IHW
IPNFZ
IPY
KQ8
M48
M~E
O5R
O5S
OK1
PGMZT
RCLKO
RIG
RNS
RPM
NPM
AAYXX
AFPKN
CITATION
7X8
5PM
ID FETCH-LOGICAL-c4697-885eaef01eb498f1b6df23844f955f15b38119ffa1b18a0228344869a216b6963
IEDL.DBID RPM
ISSN 1664-0640
IngestDate Tue Oct 22 15:12:51 EDT 2024
Tue Sep 17 21:07:26 EDT 2024
Fri Oct 25 05:55:51 EDT 2024
Fri Aug 23 01:05:59 EDT 2024
Tue Oct 15 23:52:54 EDT 2024
Tue Oct 22 15:56:10 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords anxiety
stress
memory
adenosine A2A receptors
locomotion
depression
dopamine
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4697-885eaef01eb498f1b6df23844f955f15b38119ffa1b18a0228344869a216b6963
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Joana E. Coelho and Pedro Alves have contributed equally to this work.
Edited by: Silvia Raquel Soares Ouakinin, University of Lisbon, Portugal
This article was submitted to Affective Disorders and Psychosomatic Research, a section of the journal Frontiers in Psychiatry.
Reviewed by: Chamindi Seneviratne, University of Maryland, USA; David Blum, INSERM, France
ORCID 0000-0002-3964-6197
0000-0002-9330-3507
0000-0002-2126-9485
0000-0001-6657-1111
0000-0001-8367-3005
0000-0002-3916-2598
0000-0001-5740-5904
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055866/
PMID 24982640
PQID 1542296482
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_6c5182f2b39245c2af7661390804b0d5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4055866
proquest_miscellaneous_1542296482
crossref_primary_10_3389_fpsyt_2014_00067
pubmed_primary_24982640
rcaap_revistas_10451_51216
PublicationCentury 2000
PublicationDate 2014-00-00
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – year: 2014
  text: 2014-00-00
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in psychiatry
PublicationTitleAlternate Front Psychiatry
PublicationYear 2014
Publisher Frontiers
Frontiers Media S.A
Publisher_xml – name: Frontiers
– name: Frontiers Media S.A
References 18755516 - Trends Pharmacol Sci. 2008 Oct;29(10):493-8
15904709 - Behav Brain Res. 2005 Jun 3;161(1):45-59
16946186 - Am J Psychiatry. 2006 Sep;163(9):1594-602
12086672 - Cell. 2002 Jun 14;109(6):733-43
19639292 - Handb Exp Pharmacol. 2009;(193):471-534
18241242 - Brain Pathol. 2008 Apr;18(2):211-9
17572452 - Physiol Behav. 2007 Sep 10;92(1-2):210-7
21723327 - Behav Brain Res. 2011 Oct 31;224(2):376-86
20044138 - Neuropeptides. 2010 Jun;44(3):225-32
22298379 - Glia. 2012 May;60(5):702-16
19549518 - Eur J Pharmacol. 2009 Aug 15;616(1-3):128-33
20651815 - Neurosci Bull. 2010 Aug;26(4):327-37
16470403 - Psychopharmacology (Berl). 2006 Apr;185(2):160-8
19523988 - Behav Brain Res. 2009 Dec 1;204(1):162-8
16824773 - Neurobiol Learn Mem. 2007 Jan;87(1):42-56
22371048 - Mol Psychiatry. 2013 Mar;18(3):320-31
11969069 - Ontogenez. 2002 Mar-Apr;33(2):107-10
17035531 - J Neurosci. 2006 Oct 11;26(41):10472-9
15266352 - Neuropsychopharmacology. 2004 Nov;29(11):2007-17
1876670 - Psychopharmacology (Berl). 1991;104(2):255-9
10677546 - Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1856-60
8539342 - Psychopharmacology (Berl). 1995 Sep;121(1):66-72
10601453 - J Neurophysiol. 1999 Dec;82(6):3196-203
16099045 - Neurosci Biobehav Rev. 2006;30(2):215-38
19141075 - J Neurochem. 2009 Mar;108(5):1208-19
17408759 - Trends Neurosci. 2007 May;30(5):194-202
15148138 - Arch Neurol. 2004 May;61(5):641-4
8640355 - Br J Pharmacol. 1995 Oct;116(3):2127-33
15893822 - Neurosci Biobehav Rev. 2005;29(4-5):547-69
17646043 - Prog Neurobiol. 2007 Dec;83(5):277-92
12008002 - Trends Pharmacol Sci. 2002 May;23(5):238-45
10962152 - Neurosci Lett. 2000 Sep 8;291(1):54-8
9246450 - Cold Spring Harb Symp Quant Biol. 1996;61:219-24
19325164 - Schizophr Bull. 2009 May;35(3):549-62
9347617 - Trends Neurosci. 1997 Oct;20(10):482-7
20730044 - Open Neurosci J. 2010 Jan 1;4:93-101
16123762 - Neuropsychopharmacology. 2006 Mar;31(3):525-34
23820821 - Biol Psychiatry. 2014 Jun 1;75(11):855-63
9262401 - Nature. 1997 Aug 14;388(6643):674-8
12600700 - Eur J Pharmacol. 2003 Feb 28;463(1-3):3-33
19652957 - Psychopharmacology (Berl). 2009 Oct;206(2):313-24
11378179 - Neurosci Biobehav Rev. 2001 May;25(3):235-60
18982002 - Mol Psychiatry. 2009 Aug;14 (8):764-73, 739
22981666 - Eur J Pharmacol. 2012 Nov 15;695(1-3):71-5
16043128 - Biol Psychiatry. 2005 Dec 1;58(11):843-53
20211657 - Behav Brain Res. 2010 Aug 25;211(2):148-55
11734617 - Pharmacol Rev. 2001 Dec;53(4):527-52
18289757 - Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):994-9
10663430 - Psychopharmacology (Berl). 2000 Feb;148(2):153-63
16292317 - Neuropsychopharmacology. 2006 Sep;31(9):1928-37
16123743 - Neuropsychopharmacology. 2006 May;31(5):978-87
11432985 - J Neurochem. 2001 Jul;78(1):183-98
15659214 - J Neurochem. 2005 Feb;92 (3):433-41
15922073 - Behav Brain Res. 2005 Jul 1;162(1):127-34
15893632 - Neuroscience. 2005;133(1):79-83
17329439 - J Neurosci. 2007 Feb 28;27(9):2410-5
8101381 - Pharmacol Biochem Behav. 1993 Jul;45(3):685-90
21615561 - Eur J Neurosci. 2011 Jul;34(1):12-21
1480347 - Neurosci Biobehav Rev. 1992 Winter;16(4):507-17
12700682 - Neuropsychopharmacology. 2003 Jul;28(7):1281-91
15774265 - Neurosci Lett. 2005 Apr 18;378(2):98-101
14663017 - Neurology. 2003 Dec 9;61(11 Suppl 6):S82-7
19457367 - Neuroimage. 2009 May 15;46(1):327-37
18536706 - Neuropsychopharmacology. 2009 Mar;34(4):844-56
12825092 - Neuropsychopharmacology. 2003 Sep;28(9):1694-702
559941 - Nature. 1977 Apr 21;266(5604):730-2
19513088 - Nat Rev Neurosci. 2009 Jul;10(7):519-29
17328889 - Eur J Pharmacol. 2007 May 7;562(1-2):72-6
20726873 - Epilepsia. 2010 Sep;51(9):1721-8
12044450 - Neuroscience. 2002;112(2):319-29
17986650 - J Pharmacol Exp Ther. 2008 Feb;324(2):714-24
16481441 - J Neurosci. 2006 Feb 15;26(7):2080-7
9295170 - J Neural Transm (Vienna). 1997;104(4-5):341-62
19411368 - Am J Psychiatry. 2009 Jun;166(6):702-10
19955361 - J Neurosci. 2009 Dec 2;29(48):15100-3
19007903 - Prostaglandins Other Lipid Mediat. 2009 Apr;88(3-4):68-72
16226742 - Eur J Pharmacol. 2005 Oct 31;523(1-3):71-8
23638679 - Br J Pharmacol. 2013 Aug;169(7):1600-11
21076988 - J Neural Transm (Vienna). 2010 Dec;117(12):1359-69
7813561 - Eur J Pharmacol. 1994 Sep 1;262(1-2):107-11
16803860 - J Pharmacol Exp Ther. 2006 Oct;319(1):254-9
16793068 - Neuropharmacology. 2006 Sep;51(3):631-40
14729225 - Neurosci Lett. 2004 Jan 23;355(1-2):21-4
12576292 - Prog Neurobiol. 2002 Dec;68(6):377-92
14978196 - J Pharmacol Exp Ther. 2004 Jun;309(3):936-50
Ledent (B47) 1997; 388
Kaster (B44) 2004; 355
Schiffmann (B56) 2007; 83
Braun (B51) 1997; 104
Dassesse (B83) 2001; 78
Muscat (B25) 1992; 16
Batalha (B32) 2013; 18
Short (B78) 2006; 31
Rodrigues (B85) 2005; 92
Svenningsson (B84) 2000; 97
Karcz-Kubicha (B48) 2003; 28
Papp (B39) 1991; 104
Lopes (B73) 2002; 112
Collins (B50) 2010; 211
Millan (B57) 2004; 309
Albasanz (B8) 2008; 18
Lopes (B72) 1999; 82
Brown (B61) 2009; 34
Brooks (B28) 2009; 10
Hurley (B9) 2000; 291
Fredholm (B11) 2001; 53
Yu (B63) 2009; 29
Kuzmin (B66) 2006; 31
Li (B67) 2011; 224
Rygula (B26) 2005; 162
Porsolt (B35) 1977; 266
Rétey (B2) 2006; 26
Gomes (B69) 2009; 108
Fuxe (B24) 2007; 92
Costenla (B77) 2011; 34
Girault (B13) 2004; 61
Elmenhorst (B3) 2007; 27
Urigüen (B10) 2009; 206
Yan (B27) 2010; 26
D’Aquila (B80) 1994; 262
Ciruela (B74) 2006; 26
Giménez-Llort (B53) 2007; 87
Korchounov (B21) 2010; 117
Ramos (B59) 2008; 29
El Yacoubi (B43) 2003; 61
Cryan (B42) 2005; 29
Prut (B52) 2003; 463
Howes (B16) 2009; 35
Bessa (B40) 2009; 14
Garção (B68) 2013; 169
Katsuura (B65) 2010; 44
Keedwell (B18) 2005; 58
Jain (B49) 1995; 116
Simões do Couto (B41) 2012; 695
Mayford (B31) 1996; 61
Bekris (B34) 2005; 161
Hirano (B81) 2007; 562
Lam (B6) 2005; 378
Detke (B37) 1995; 121
Ribeiro (B12) 2002; 68
Cryan (B36) 2002; 23
Soria (B62) 2006; 31
Matos (B76) 2012; 60
Meyer (B22) 2006; 163
Rebola (B75) 2005; 133
Strekalova (B33) 2004; 29
Listos (B71) 2005; 523
Castañà (B46) 2006; 51
Lobato (B45) 2008; 32
Popova (B30) 2002; 33
Yao (B82) 2002; 109
Alsene (B7) 2003; 28
Sadock (B20) 2009
Wei (B54) 2013; 75
Castagne (B38) 2009; 616
Wacker (B19) 2009; 46
Pizzagalli (B17) 2009; 166
Bilbao (B60) 2006; 185
Boison (B4) 2010; 4
Ferrà (B23) 1997; 20
Li (B86) 2006; 319
McAuley (B58) 2009; 204
Pierce (B15) 2006; 30
Choleris (B29) 2001; 25
El Yacoubi (B55) 2000; 148
Zhao (B70) 2009; 88
Sebastião (B1) 2009
Jutkiewicz (B64) 2008; 324
Bjorklund (B14) 2007; 30
Simon (B79) 1993; 45
Van Dycke (B5) 2010; 51
References_xml – volume: 163
  start-page: 1594
  issue: 9
  year: 2006
  ident: B22
  article-title: Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.163.9.1594
  contributor:
    fullname: Meyer
– volume: 34
  start-page: 844
  issue: 4
  year: 2009
  ident: B61
  article-title: A differential role for the adenosine A2A receptor in opiate reinforcement vs opiate-seeking behavior
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2008.72
  contributor:
    fullname: Brown
– volume: 117
  start-page: 1359
  issue: 12
  year: 2010
  ident: B21
  article-title: Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation
  publication-title: J Neural Transm
  doi: 10.1007/s00702-010-0454-z
  contributor:
    fullname: Korchounov
– volume: 169
  start-page: 1600
  issue: 7
  year: 2013
  ident: B68
  article-title: Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.12234
  contributor:
    fullname: Garção
– volume: 10
  start-page: 519
  issue: 7
  year: 2009
  ident: B28
  article-title: Tests to assess motor phenotype in mice: a user’s guide
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn2652
  contributor:
    fullname: Brooks
– volume: 26
  start-page: 10472
  issue: 41
  year: 2006
  ident: B2
  article-title: Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1538-06.2006
  contributor:
    fullname: Rétey
– volume: 224
  start-page: 376
  issue: 2
  year: 2011
  ident: B67
  article-title: Behavioural and neuronal activation after microinjections of AMPA and NMDA into the perifornical lateral hypothalamus in rats
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2011.06.021
  contributor:
    fullname: Li
– volume: 33
  start-page: 107
  year: 2002
  ident: B30
  article-title: In vitro development of murine embryos using different types of microinjections
  publication-title: Ontogenez
  doi: 10.1023/A:1014912128311
  contributor:
    fullname: Popova
– volume: 58
  start-page: 843
  issue: 11
  year: 2005
  ident: B18
  article-title: The neural correlates of anhedonia in major depressive disorder
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2005.05.019
  contributor:
    fullname: Keedwell
– volume: 75
  start-page: 855
  issue: 11
  year: 2013
  ident: B54
  article-title: Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2013.05.003
  contributor:
    fullname: Wei
– volume: 82
  start-page: 196
  issue: 3
  year: 1999
  ident: B72
  article-title: Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats
  publication-title: J Neurophysiol
  contributor:
    fullname: Lopes
– volume: 161
  start-page: 45
  issue: 1
  year: 2005
  ident: B34
  article-title: Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2005.01.005
  contributor:
    fullname: Bekris
– volume: 78
  start-page: 183
  issue: 1
  year: 2001
  ident: B83
  article-title: Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2001.00389.x
  contributor:
    fullname: Dassesse
– volume: 388
  start-page: 674
  issue: 6643
  year: 1997
  ident: B47
  article-title: Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
  publication-title: Nature
  doi: 10.1038/41771
  contributor:
    fullname: Ledent
– volume: 204
  start-page: 162
  issue: 1
  year: 2009
  ident: B58
  article-title: Wistar-Kyoto rats as an animal model of anxiety vulnerability: support for a hypervigilance hypothesis
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2009.05.036
  contributor:
    fullname: McAuley
– volume: 88
  start-page: 68
  issue: 3–4
  year: 2009
  ident: B70
  article-title: Central prostaglandin D(2) exhibits anxiolytic-like activity via the DP(1) receptor in mice
  publication-title: Prostaglandins Other Lipid Mediat
  doi: 10.1016/j.prostaglandins.2008.10.001
  contributor:
    fullname: Zhao
– volume: 104
  start-page: 341
  issue: 4–5
  year: 1997
  ident: B51
  article-title: Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications
  publication-title: J Neural Transm
  doi: 10.1007/BF01277656
  contributor:
    fullname: Braun
– volume: 92
  start-page: 433
  issue: 3
  year: 2005
  ident: B85
  article-title: Co-localization and functional interaction between adenosine A(2A) and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2004.02887.x
  contributor:
    fullname: Rodrigues
– start-page: 471
  volume-title: Handb Exp Pharmacol
  year: 2009
  ident: B1
  article-title: Adenosine receptors and the central nervous system
  contributor:
    fullname: Sebastião
– volume: 23
  start-page: 238
  issue: 5
  year: 2002
  ident: B36
  article-title: Assessing antidepressant activity in rodents: recent developments and future needs
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/S0165-6147(02)02017-5
  contributor:
    fullname: Cryan
– volume: 116
  start-page: 2127
  issue: 3
  year: 1995
  ident: B49
  article-title: Anxiolytic activity of adenosine receptor activation in mice
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.1995.tb16421.x
  contributor:
    fullname: Jain
– volume: 523
  start-page: 71
  issue: 1–3
  year: 2005
  ident: B71
  article-title: Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2005.07.025
  contributor:
    fullname: Listos
– volume: 18
  start-page: 320
  year: 2013
  ident: B32
  article-title: Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2012.8
  contributor:
    fullname: Batalha
– volume: 35
  start-page: 549
  issue: 3
  year: 2009
  ident: B16
  article-title: The dopamine hypothesis of schizophrenia: version III – the final common pathway
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp006
  contributor:
    fullname: Howes
– volume: 31
  start-page: 1928
  issue: 9
  year: 2006
  ident: B66
  article-title: Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300959
  contributor:
    fullname: Kuzmin
– volume: 30
  start-page: 194
  issue: 5
  year: 2007
  ident: B14
  article-title: Dopamine neuron systems in the brain: an update
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2007.03.006
  contributor:
    fullname: Bjorklund
– volume: 51
  start-page: 1721
  issue: 9
  year: 2010
  ident: B5
  article-title: Continuous local intrahippocampal delivery of adenosine reduces seizure frequency in rats with spontaneous seizures
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2010.02700.x
  contributor:
    fullname: Van Dycke
– volume: 31
  start-page: 978
  issue: 5
  year: 2006
  ident: B62
  article-title: The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300876
  contributor:
    fullname: Soria
– volume: 25
  start-page: 235
  issue: 3
  year: 2001
  ident: B29
  article-title: A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/S0149-7634(01)00011-2
  contributor:
    fullname: Choleris
– volume: 16
  start-page: 507
  issue: 4
  year: 1992
  ident: B25
  article-title: Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/S0149-7634(05)80192-7
  contributor:
    fullname: Muscat
– volume: 87
  start-page: 42
  issue: 1
  year: 2007
  ident: B53
  article-title: Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain
  publication-title: Neurobiol Learn Mem
  doi: 10.1016/j.nlm.2006.05.004
  contributor:
    fullname: Giménez-Llort
– start-page: 1875
  volume-title: Kaplan and Sadock’s Comprehensive Textbook of Psychiatry
  year: 2009
  ident: B20
  contributor:
    fullname: Sadock
– volume: 20
  start-page: 482
  issue: 10
  year: 1997
  ident: B23
  article-title: Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia
  publication-title: Trends Neurosci
  doi: 10.1016/S0166-2236(97)01096-5
  contributor:
    fullname: FerrÃ
– volume: 29
  start-page: 2007
  issue: 11
  year: 2004
  ident: B33
  article-title: Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300532
  contributor:
    fullname: Strekalova
– volume: 28
  start-page: 1281
  issue: 7
  year: 2003
  ident: B48
  article-title: Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300167
  contributor:
    fullname: Karcz-Kubicha
– volume: 463
  start-page: 3
  issue: 1–3
  year: 2003
  ident: B52
  article-title: The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(03)01272-X
  contributor:
    fullname: Prut
– volume: 378
  start-page: 98
  issue: 2
  year: 2005
  ident: B6
  article-title: Association study of A2a adenosine receptor genetic polymorphism in panic disorder
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2004.12.012
  contributor:
    fullname: Lam
– volume: 616
  start-page: 128
  issue: 1–3
  year: 2009
  ident: B38
  article-title: Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2009.06.018
  contributor:
    fullname: Castagne
– volume: 31
  start-page: 525
  issue: 3
  year: 2006
  ident: B78
  article-title: Receptor crosstalk: characterization of mice deficient in dopamine D1 and adenosine A2A receptors
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300852
  contributor:
    fullname: Short
– volume: 4
  start-page: 93
  year: 2010
  ident: B4
  article-title: Adenosine dysfunction and adenosine kinase in epileptogenesis
  publication-title: Open Neurosci J
  doi: 10.2174/1874082001004020093
  contributor:
    fullname: Boison
– volume: 32
  start-page: 994
  issue: 4
  year: 2008
  ident: B45
  article-title: Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2008.01.012
  contributor:
    fullname: Lobato
– volume: 18
  start-page: 211
  issue: 2
  year: 2008
  ident: B8
  article-title: Up-regulation of adenosine receptors in the frontal cortex in Alzheimer’s disease
  publication-title: Brain Pathol
  doi: 10.1111/j.1750-3639.2007.00112.x
  contributor:
    fullname: Albasanz
– volume: 291
  start-page: 54
  issue: 1
  year: 2000
  ident: B9
  article-title: Adenosine A(2A) receptor mRNA expression in Parkinson’s disease
  publication-title: Neurosci Lett
  doi: 10.1016/S0304-3940(00)01371-9
  contributor:
    fullname: Hurley
– volume: 104
  start-page: 255
  issue: 2
  year: 1991
  ident: B39
  article-title: An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress
  publication-title: Psychopharmacology
  doi: 10.1007/BF02244188
  contributor:
    fullname: Papp
– volume: 695
  start-page: 71
  issue: 1–3
  year: 2012
  ident: B41
  article-title: Escitalopram improves memory deficits induced by maternal separation in the rat
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2012.08.020
  contributor:
    fullname: Simões do Couto
– volume: 166
  start-page: 702
  issue: 6
  year: 2009
  ident: B17
  article-title: Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2008.08081201
  contributor:
    fullname: Pizzagalli
– volume: 61
  start-page: S82
  issue: 11 Suppl 6
  year: 2003
  ident: B43
  article-title: Adenosine A2A receptors and depression
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000095220.87550.F6
  contributor:
    fullname: El Yacoubi
– volume: 29
  start-page: 493
  issue: 10
  year: 2008
  ident: B59
  article-title: Animal models of anxiety: do I need multiple tests?
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2008.07.005
  contributor:
    fullname: Ramos
– volume: 44
  start-page: 225
  issue: 3
  year: 2010
  ident: B65
  article-title: Modulation of feeding and locomotion through mu and delta opioid receptor signaling in the nucleus accumbens
  publication-title: Neuropeptides
  doi: 10.1016/j.npep.2009.12.002
  contributor:
    fullname: Katsuura
– volume: 133
  start-page: 79
  year: 2005
  ident: B75
  article-title: Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2005.01.054
  contributor:
    fullname: Rebola
– volume: 29
  start-page: 15100
  issue: 48
  year: 2009
  ident: B63
  article-title: Genetic deletion of A2A adenosine receptors in the striatum selectively impairs habit formation
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4215-09.2009
  contributor:
    fullname: Yu
– volume: 109
  start-page: 733
  issue: 6
  year: 2002
  ident: B82
  article-title: beta gamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00763-8
  contributor:
    fullname: Yao
– volume: 309
  start-page: 936
  issue: 3
  year: 2004
  ident: B57
  article-title: S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.103.062463
  contributor:
    fullname: Millan
– volume: 108
  start-page: 1208
  issue: 5
  year: 2009
  ident: B69
  article-title: GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2009.05876.x
  contributor:
    fullname: Gomes
– volume: 61
  start-page: 641
  issue: 5
  year: 2004
  ident: B13
  article-title: The neurobiology of dopamine signaling
  publication-title: Arch Neurol
  doi: 10.1001/archneur.61.5.641
  contributor:
    fullname: Girault
– volume: 27
  start-page: 2410
  issue: 9
  year: 2007
  ident: B3
  article-title: Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5066-06.2007
  contributor:
    fullname: Elmenhorst
– volume: 34
  start-page: 12
  year: 2011
  ident: B77
  article-title: Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing
  publication-title: Eur J Neurosci
  doi: 10.1111/j.1460-9568.2011.07719.x
  contributor:
    fullname: Costenla
– volume: 30
  start-page: 215
  issue: 2
  year: 2006
  ident: B15
  article-title: The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2005.04.016
  contributor:
    fullname: Pierce
– volume: 266
  start-page: 730
  issue: 5604
  year: 1977
  ident: B35
  article-title: Depression: a new animal model sensitive to antidepressant treatments
  publication-title: Nature
  doi: 10.1038/266730a0
  contributor:
    fullname: Porsolt
– volume: 185
  start-page: 160
  issue: 2
  year: 2006
  ident: B60
  article-title: Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-005-0284-0
  contributor:
    fullname: Bilbao
– volume: 112
  start-page: 319
  year: 2002
  ident: B73
  article-title: Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(02)00080-5
  contributor:
    fullname: Lopes
– volume: 26
  start-page: 2080
  year: 2006
  ident: B74
  article-title: Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.3574-05.2006
  contributor:
    fullname: Ciruela
– volume: 28
  start-page: 1694
  issue: 9
  year: 2003
  ident: B7
  article-title: Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300232
  contributor:
    fullname: Alsene
– volume: 324
  start-page: 714
  issue: 2
  year: 2008
  ident: B64
  article-title: The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-met hoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.107.123844
  contributor:
    fullname: Jutkiewicz
– volume: 60
  start-page: 702
  issue: 5
  year: 2012
  ident: B76
  article-title: Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes
  publication-title: Glia
  doi: 10.1002/glia.22290
  contributor:
    fullname: Matos
– volume: 92
  start-page: 210
  issue: 1–2
  year: 2007
  ident: B24
  article-title: Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function
  publication-title: Physiol Behav
  doi: 10.1016/j.physbeh.2007.05.034
  contributor:
    fullname: Fuxe
– volume: 162
  start-page: 127
  issue: 1
  year: 2005
  ident: B26
  article-title: Anhedonia and motivational deficits in rats: impact of chronic social stress
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2005.03.009
  contributor:
    fullname: Rygula
– volume: 29
  start-page: 547
  issue: 4–5
  year: 2005
  ident: B42
  article-title: Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2005.03.008
  contributor:
    fullname: Cryan
– volume: 68
  start-page: 377
  issue: 6
  year: 2002
  ident: B12
  article-title: Adenosine receptors in the nervous system: pathophysiological implications
  publication-title: Prog Neurobiol
  doi: 10.1016/S0301-0082(02)00155-7
  contributor:
    fullname: Ribeiro
– volume: 46
  start-page: 327
  issue: 1
  year: 2009
  ident: B19
  article-title: The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2009.01.058
  contributor:
    fullname: Wacker
– volume: 206
  start-page: 313
  issue: 2
  year: 2009
  ident: B10
  article-title: Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-009-1608-2
  contributor:
    fullname: Urigüen
– volume: 211
  start-page: 148
  issue: 2
  year: 2010
  ident: B50
  article-title: Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2010.03.003
  contributor:
    fullname: Collins
– volume: 61
  start-page: 219
  year: 1996
  ident: B31
  article-title: CaMKII function in the nervous system explored from a genetic perspective
  publication-title: Cold Spring Harb Symp Quant Biol
  doi: 10.1101/SQB.1996.061.01.024
  contributor:
    fullname: Mayford
– volume: 562
  start-page: 72
  issue: 1–2
  year: 2007
  ident: B81
  article-title: Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2007.01.063
  contributor:
    fullname: Hirano
– volume: 121
  start-page: 66
  issue: 1
  year: 1995
  ident: B37
  article-title: Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants
  publication-title: Psychopharmacology
  doi: 10.1007/BF02245592
  contributor:
    fullname: Detke
– volume: 262
  start-page: 107
  issue: 1–2
  year: 1994
  ident: B80
  article-title: Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(94)90033-7
  contributor:
    fullname: D’Aquila
– volume: 355
  start-page: 21
  issue: 1–2
  year: 2004
  ident: B44
  article-title: Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2003.10.040
  contributor:
    fullname: Kaster
– volume: 83
  start-page: 277
  issue: 5
  year: 2007
  ident: B56
  article-title: Adenosine A2A receptors and basal ganglia physiology
  publication-title: Prog Neurobiol
  doi: 10.1016/j.pneurobio.2007.05.001
  contributor:
    fullname: Schiffmann
– volume: 97
  start-page: 1856
  issue: 4
  year: 2000
  ident: B84
  article-title: Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.97.4.1856
  contributor:
    fullname: Svenningsson
– volume: 45
  start-page: 685
  issue: 3
  year: 1993
  ident: B79
  article-title: Anxiogenic-like effects induced by stimulation of dopamine receptors
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(93)90525-X
  contributor:
    fullname: Simon
– volume: 51
  start-page: 631
  issue: 3
  year: 2006
  ident: B46
  article-title: Attenuation of nicotine-induced rewarding effects in A2A knockout mice
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2006.05.005
  contributor:
    fullname: CastañÃ
– volume: 53
  start-page: 527
  issue: 4
  year: 2001
  ident: B11
  article-title: International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors
  publication-title: Pharmacol Rev
  contributor:
    fullname: Fredholm
– volume: 26
  start-page: 327
  issue: 4
  year: 2010
  ident: B27
  article-title: Behavioral animal models of depression
  publication-title: Neurosci Bull
  doi: 10.1007/s12264-010-0323-7
  contributor:
    fullname: Yan
– volume: 14
  start-page: 764
  issue: 8
  year: 2009
  ident: B40
  article-title: The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2008.119
  contributor:
    fullname: Bessa
– volume: 148
  start-page: 153
  issue: 2
  year: 2000
  ident: B55
  article-title: The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists
  publication-title: Psychopharmacology
  doi: 10.1007/s002130050037
  contributor:
    fullname: El Yacoubi
– volume: 319
  start-page: 254
  issue: 1
  year: 2006
  ident: B86
  article-title: Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.106.103143
  contributor:
    fullname: Li
SSID ssj0000399365
Score 2.342566
Snippet Copyright: © 2014 Coelho, Alves, Canas, Valadas, Shmidt, Batalha, Ferreira, Ribeiro, Bader, Cunha, do Couto and Lopes. This is an open-access article...
Adenosine A2A receptors (A2AR) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with dopamine...
Adenosine A 2A receptors (A 2A R) are a sub-type of receptors enriched in basal ganglia, activated by the neuromodulator adenosine, which interact with...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
rcaap
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 67
SubjectTerms Adenosine A2A receptors
Alzheimer's disease
Anxiety
Depression
Dopamine
Locomotion
Memory
Psychiatry
Stress
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BatwwEBUhveRSWtq0TpqiQi-BmEiKJFu5bUtDKLS5JJCbqrElmot2ySaQ_n1nJGezSwu99OCLbZA9z_J7Iw1vGPsYhOuiHWPb6eha3QfRBrDQQhAnA2iNIpuWBr59t-dX-uu1uV5r9UU1YdUeuAbu2A4GJXBSgESuzaBC6pBSMFPvhQYxVvdS4daSqfIPJt61pu5LYhbmjtNi-YtqJyW5ZYvSVv6Jh4pd_9805p-lks9uhxAWaxx09oI9n8Qjn9WHfsm2Yn7Fflzg1xgfpoLWzOeJh5EswFE_8pmacfynxQU11eE3mSPgy1M-VXFwvH1VCpuPOBLbvLb14SGPeDxQRedrdnX25fLzeTv1TWgHTHaRdHoTQ0xCRtCuTxLsmJCZtU7OmCQNIEtLl1KQIBEcMsDBJM26oKQFizNyl23neY5vGVcwDGksu75RO6GgiwnI4_1EqwQQGnb4GEW_qPYYHtMKirgvEfcUcV8i3rBPFObVfWRsXU4g3H6C2_8L7oZ9eATJ40Sg3Y2Q4_x-6VELKtpD7lXD3lTQVkNhjolplBYN6zbg3HiWzSv55mcx20ZBa3prG7ZXgPdUfI26HccjZx6Peknavf_xZvtsh2JVl3fese272_t4gILnDt6Xb_s3oiT80Q
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_07sUXUfzqeUoEX4SrNtkkbQWR-nEc4geIC_cWkjY5DyTd2-7B3n_vTNo9XdwHX9vQhJlM5jeZ6W8AntuiLr3ufF5KX-eyskVunXa5s8WsdVIiyKargS9f9clcfjpVp39-j54EOOwM7aif1Hz56-X64uotGvwbijjR374Ki-GKyiI5EWHj6XsT9gXRclEh3wT207lMvjj1luRay5xSWGPecudHtvxUovPfhUH_LaXcX7bWLv7yUcd34PYELlkz7oa7cMPHe2C_4W7166ngNbI-sKYjinDEl6wRDUPk6BfUdIedR_bdrobXbOQ0HhgO_7AplY1H7HPf9mPbnyNmY8eauKaSz_swP_744_1JPjVWyFuMhtErVcpbHwrunayrwJ3uArpuKUOtVODKoRvndQiWO47aI4YcjOJ0bQXXTqPJPoC92Ef_CJhwbRu6lBb2si6EK31wRAI_kyI4ZzN4sRGjWYz8GQbjDhK5SSI3JHKTRJ7BO5Lz9Thivk4P-uWZmQzJ6FZhSBSEQ2AnVStsKBFizGpEvtIVncrg2UZLBi2F0h82-v5yMAgWBSWZK5HBw1Fr11NhEIpxliwyKLf0ubWW7Tfx_Gdi40bEqyqtMzhImjdUnY3AHucj6h6DgIrrg_9Y1GO4RaIYr3cOYW-1vPRPEPCs3NO0j38DnVD8sA
  priority: 102
  providerName: Scholars Portal
Title Overexpression of Adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety
URI http://hdl.handle.net/10451/51216
https://www.ncbi.nlm.nih.gov/pubmed/24982640
https://search.proquest.com/docview/1542296482
https://pubmed.ncbi.nlm.nih.gov/PMC4055866
https://doaj.org/article/6c5182f2b39245c2af7661390804b0d5
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXacuGCQHylQGUkLkhNN87aTswtFKoKsYAQlXqzbMcuK1En2t1K5d8z4yTVruDEJYfEysfM2PPGfnkm5I0pVOVl6_OKe5Xz2hS5sdLm1hRzZzkHkI1TA4sv8vyCf7oUl3tETP_CJNK-s8uT-Ov6JC5_Jm5lf-1mE09s9m1xCiBD1FLO9sk-BOhWiZ6GX0y5UgxLklCAqVno17-RNslQKBtGZxQA5gpwNc54bGWjJNr_L6T5N2Hy3soZ029lorOH5MEIIWkzvOojsufjY2K-Qkz625HWGmkXaNOiEDigSNqUDQV86HvcWocuI_1uNut3dFAuXlNo_mEixMZj-rlz3bC5zzE1saVNvEVi5xNycfbxx-l5Pm6fkDuoeSH31MIbHwrmLXxtYFa2ARI050EJEZiwkKyZCsEwy8BHqIMDtZpUpmTSSuiYT8lB7KJ_TmhpnQttWvz1XBWlrXywKPU-52Ww1mTk7WRG3Q8qGRqqC7S-TtbXaH2drJ-R92jnu3aob51OdKsrPXpZSyeg8AmlBfjGhStNqABIzBXgW26LVmTk9eQlDf0BFzlM9N3NWgMkLHEpuS4z8mzw2t2jJq9npNrx58677F6BEEya22PIZeQweV4jBxvgOzwPBXo0wCYmD__7ti_IfTTQMLXzkhxsVjf-FYCdjT1KkwRwXPD6KAX6Hx-G_9c
link.rule.ids 230,315,730,783,787,867,888,2109,4033,24332,27937,27938,27939,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL0q7QI2PMSjKS8jsUFqZpKM7UzYhUI1wExBqEXdWbZjwwjqRPOQCl_PtZNUM8AGtnGUh8917rn2yTHAc5kUueGViXNqipiOZRJLxVWsZDLSilIk2X5qYHbCJ2f03Tk73wHW_wsTRPtazQfu-8XAzb8GbWVzoYe9Tmz4cXaEJIONOR9egz0crwnfKNLDB9gnXc7aRUkswYqhbZY_vHAy9VbZ-H32FsC0QGbt5zw28lGw7f8b1_xTMrm30FI2G7no-BZ87t-ilaB8G6xXaqB__mbw-M-veRtuduyUlG3zHdgx7i7IDxju5rJTzDpSW1JW3mMcCSops5Ig9TSN37WHzB35JFfLl6Q1RV4SPP11r7V1h2Ra67rdN-iQSFeR0l16zeg9ODt-c3o0ibudGWKN5TSmtTEz0tgkNQq70aaKVxZzP6W2YMymTCEPSAtrZapShN9b7GAZyAuZpVxxHPP3YdfVzuwDyZTWtgrryoYWSaZyY5V3kR_RzColI3jR4yOa1oBDYOHiYRUBVuFhFQHWCF55AK_O89bZ4UC9-CK6nhVcM6ypbKaQGVKmM2lz5CijAqkzVUnFInjWwy9wqPn1E-lMvV4KZJuZX6UeZxE8aMPh6lZ9OEWQbwXK1rNstyDswc67gzmCgxBSwsu7sTLA-3nvH4GMLOUH_33Zp3B9cjqbiunbk_cP4YbvrHYG6RHsrhZr8xg51Uo9CSPoFz6ZIBE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaglRAXHuLRlJeRuCA1u0nWdhJuoWVVoC0VolLFxbIdG1ZQJ9qHVPj1zDhJtQucek2sOPbM2N_Yn74h5JVKytyK2sY5s2XMCpXESgsda5VMjGYMQDYeDRyfiMMz9uGcn6-V-gqkfaNnI__zYuRn3wO3sr0w44EnNj493geQwQshxm3txjfJNsRsUqwl6mERxo1X8O5iEtKwcuzaxS8kT6Yolw1rNMoAsxLQNZ57rO1JQbr_f3jzX9rk9two1a7tR9O75Oswko6G8mO0WuqR-f2XyOO1hnqP3OlRKq26JvfJDesfEPUJ3N5e9sxZTxtHqxq1xgGo0iqrKEBQ22L1Hjrz9LNaLt7QThx5QaH5wcC59Xv0qDFNVz9ojypf08pfInf0ITmbvvuyfxj3FRpiA2k1bG8Ft8q6JLUaptKlWtQOMABjruTcpVwDHkhL51SqU3ADlNqBdFCUKkuFFhD7j8iWb7zdITTTxrg63C9bViaZzq3TqCY_YZnTWkXk9WAj2XZCHBISGDStDKaVaFoZTBuRt2jEq3YooR0eNPNvsp9dKQyH3MplGhAi4yZTLgesMikBQjOd1DwiLwcXkBByeI-ivG1WCwmoM8Pb6iKLyOPOJa66GlwqIvmGs2z8y-YbMH2Q9e5NHZHd4FYSad6QIUB_qAEkAZmlYvfan31Bbp0eTOXR-5OPT8htnKvuIOkp2VrOV_YZQKulfh6C6A9KyCKR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overexpression+of+Adenosine+A2A+Receptors+in+Rats%3A+Effects+on+Depression%2C+Locomotion%2C+and+Anxiety&rft.jtitle=Frontiers+in+psychiatry&rft.au=Coelho%2C+Joana+E&rft.au=Alves%2C+Pedro&rft.au=Canas%2C+Paula+M&rft.au=Valadas%2C+Jorge+S&rft.date=2014&rft.issn=1664-0640&rft.eissn=1664-0640&rft.volume=5&rft.spage=67&rft.epage=67&rft_id=info:doi/10.3389%2Ffpsyt.2014.00067&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-0640&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-0640&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-0640&client=summon